Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis

Osteosarcoma (OS) is a malignant tumor originating from mesenchymal tissue. Pulmonary metastasis is usually present upon initial diagnosis, and metastasis is the primary factor affecting the poor prognosis of patients with OS. Current research shows that the ability to regulate the cellular microenv...

Full description

Bibliographic Details
Main Authors: Jianghu Zhou, Fengjun Lan, Miao Liu, Fengyan Wang, Xu Ning, Hua Yang, Hong Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1350187/full
_version_ 1797347881280077824
author Jianghu Zhou
Fengjun Lan
Miao Liu
Fengyan Wang
Xu Ning
Hua Yang
Hong Sun
author_facet Jianghu Zhou
Fengjun Lan
Miao Liu
Fengyan Wang
Xu Ning
Hua Yang
Hong Sun
author_sort Jianghu Zhou
collection DOAJ
description Osteosarcoma (OS) is a malignant tumor originating from mesenchymal tissue. Pulmonary metastasis is usually present upon initial diagnosis, and metastasis is the primary factor affecting the poor prognosis of patients with OS. Current research shows that the ability to regulate the cellular microenvironment is essential for preventing the distant metastasis of OS, and anoxic microenvironments are important features of solid tumors. During hypoxia, hypoxia-inducible factor-1α (HIF-1α) expression levels and stability increase. Increased HIF-1α promotes tumor vascular remodeling, epithelial-mesenchymal transformation (EMT), and OS cells invasiveness; this leads to distant metastasis of OS cells. HIF-1α plays an essential role in the mechanisms of OS metastasis. In order to develop precise prognostic indicators and potential therapeutic targets for OS treatment, this review examines the molecular mechanisms of HIF-1α in the distant metastasis of OS cells; the signal transduction pathways mediated by HIF-1α are also discussed.
first_indexed 2024-03-08T11:55:19Z
format Article
id doaj.art-511c00d47f2d4c58bbc635f769333c74
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-08T11:55:19Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-511c00d47f2d4c58bbc635f769333c742024-01-24T04:17:49ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122024-01-011510.3389/fphar.2024.13501871350187Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasisJianghu Zhou0Fengjun Lan1Miao Liu2Fengyan Wang3Xu Ning4Hua Yang5Hong Sun6Department of Orthopaedics, Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaDepartment of Orthopaedics, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Orthopaedics, Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaDepartment of Orthopaedics, Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaDepartment of Orthopaedics, Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaDepartment of Orthopaedics, Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaDepartment of Orthopaedics, Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaOsteosarcoma (OS) is a malignant tumor originating from mesenchymal tissue. Pulmonary metastasis is usually present upon initial diagnosis, and metastasis is the primary factor affecting the poor prognosis of patients with OS. Current research shows that the ability to regulate the cellular microenvironment is essential for preventing the distant metastasis of OS, and anoxic microenvironments are important features of solid tumors. During hypoxia, hypoxia-inducible factor-1α (HIF-1α) expression levels and stability increase. Increased HIF-1α promotes tumor vascular remodeling, epithelial-mesenchymal transformation (EMT), and OS cells invasiveness; this leads to distant metastasis of OS cells. HIF-1α plays an essential role in the mechanisms of OS metastasis. In order to develop precise prognostic indicators and potential therapeutic targets for OS treatment, this review examines the molecular mechanisms of HIF-1α in the distant metastasis of OS cells; the signal transduction pathways mediated by HIF-1α are also discussed.https://www.frontiersin.org/articles/10.3389/fphar.2024.1350187/fullosteosarcomaHIF-1ɑmetastasiscellular microenvironmentsignaling pathwaystherapy
spellingShingle Jianghu Zhou
Fengjun Lan
Miao Liu
Fengyan Wang
Xu Ning
Hua Yang
Hong Sun
Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
Frontiers in Pharmacology
osteosarcoma
HIF-1ɑ
metastasis
cellular microenvironment
signaling pathways
therapy
title Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
title_full Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
title_fullStr Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
title_full_unstemmed Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
title_short Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
title_sort hypoxia inducible factor 1ɑ as a potential therapeutic target for osteosarcoma metastasis
topic osteosarcoma
HIF-1ɑ
metastasis
cellular microenvironment
signaling pathways
therapy
url https://www.frontiersin.org/articles/10.3389/fphar.2024.1350187/full
work_keys_str_mv AT jianghuzhou hypoxiainduciblefactor1ɑasapotentialtherapeutictargetforosteosarcomametastasis
AT fengjunlan hypoxiainduciblefactor1ɑasapotentialtherapeutictargetforosteosarcomametastasis
AT miaoliu hypoxiainduciblefactor1ɑasapotentialtherapeutictargetforosteosarcomametastasis
AT fengyanwang hypoxiainduciblefactor1ɑasapotentialtherapeutictargetforosteosarcomametastasis
AT xuning hypoxiainduciblefactor1ɑasapotentialtherapeutictargetforosteosarcomametastasis
AT huayang hypoxiainduciblefactor1ɑasapotentialtherapeutictargetforosteosarcomametastasis
AT hongsun hypoxiainduciblefactor1ɑasapotentialtherapeutictargetforosteosarcomametastasis